BACKGROUND/AIMS: The mitotic kinesin superfamily protein KIF14 is essential for cytokinesis and chromosome segregation, and increased KIF14 expression is related to a variety of human cancers. However, the role of KIF14 in the development and malignant progression of astrocytomas and the underlying mechanisms remain unclear. The present study examined the relation between KIF14 and the pathogenesis of malignant astrocytoma. METHODS AND RESULTS: The role of KIF14 in astrocytoma development and progression was investigated by analyzing KIF14 expression using SYBR Green quantitative real-time RT-PCR, western blotting and immunohistochemistry in human astrocytoma and normal brain tissues. KIF14 expression was higher in astrocytoma samples, and was positively correlated with pathological grade and proliferative activity indicated by Ki-67 staining. SiRNA knockdown of KIF14 inhibited tumor growth in vitro and in vivo, attenuated anchorage-independent growth, and induced G2/M phase arrest, cytokinesis failure and apoptosis in glioblastoma cell lines in association with decreased AKT phosphorylation and activity. CONCLUSIONS: The upregulation of KIF14 in astrocytoma is associated with disease severity, and suppression of KIF14 inhibits cell proliferation and induces apoptosis through a mechanism involving the inactivation of AKT signaling, suggesting that KIF14 plays an important role in astrocytoma tumorigenesis and could be a promising molecular target for anticancer therapy.
BACKGROUND/AIMS: The mitotic kinesin superfamily protein KIF14 is essential for cytokinesis and chromosome segregation, and increased KIF14 expression is related to a variety of humancancers. However, the role of KIF14 in the development and malignant progression of astrocytomas and the underlying mechanisms remain unclear. The present study examined the relation between KIF14 and the pathogenesis of malignant astrocytoma. METHODS AND RESULTS: The role of KIF14 in astrocytoma development and progression was investigated by analyzing KIF14 expression using SYBR Green quantitative real-time RT-PCR, western blotting and immunohistochemistry in humanastrocytoma and normal brain tissues. KIF14 expression was higher in astrocytoma samples, and was positively correlated with pathological grade and proliferative activity indicated by Ki-67 staining. SiRNA knockdown of KIF14 inhibited tumor growth in vitro and in vivo, attenuated anchorage-independent growth, and induced G2/M phase arrest, cytokinesis failure and apoptosis in glioblastoma cell lines in association with decreased AKT phosphorylation and activity. CONCLUSIONS: The upregulation of KIF14 in astrocytoma is associated with disease severity, and suppression of KIF14 inhibits cell proliferation and induces apoptosis through a mechanism involving the inactivation of AKT signaling, suggesting that KIF14 plays an important role in astrocytoma tumorigenesis and could be a promising molecular target for anticancer therapy.
Authors: Zhenxing Zhang; Xiaofeng Song; He Tian; Ye Miao; Xu Feng; Yang Li; Honglei Wang Journal: Am J Transl Res Date: 2017-03-15 Impact factor: 4.060
Authors: Theresa M Thole; Marco Lodrini; Johannes Fabian; Jasmin Wuenschel; Sebastian Pfeil; Thomas Hielscher; Annette Kopp-Schneider; Ulrike Heinicke; Simone Fulda; Olaf Witt; Angelika Eggert; Matthias Fischer; Hedwig E Deubzer Journal: Cell Death Dis Date: 2017-03-02 Impact factor: 8.469
Authors: Kamakshi Sishtla; Natalie Pitt; Mehdi Shadmand; Michael N O'Hare; Rania S Sulaiman; Anthony L Sinn; Keith Condon; Karen E Pollok; George E Sandusky; Timothy W Corson Journal: Sci Rep Date: 2018-11-01 Impact factor: 4.379
Authors: Bao-Ai Han; Xiu-Ping Yang; Davood K Hosseini; Po Zhang; Ya Zhang; Jin-Tao Yu; Shan Chen; Fan Zhang; Tao Zhou; Hai-Ying Sun Journal: Sci Rep Date: 2020-06-16 Impact factor: 4.379